Cumberland Pharmaceuticals Inc.
CPIX
$6.29
-$0.33-4.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -133.02% | 27.26% | -- | -- |
| Total Depreciation and Amortization | -- | 17.66% | 0.31% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 0.68% | 3,468.57% | -- | -- |
| Change in Net Operating Assets | -- | 6,689.11% | -103.75% | -- | -- |
| Cash from Operations | -- | 12,800.00% | -98.40% | -77.81% | -78.36% |
| Capital Expenditure | -- | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 98.01% | -360.76% | -- | -- |
| Cash from Investing | -- | 98.01% | -344.89% | -341.62% | 123.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -3.02% | -81.11% | -- | -- |
| Cash from Financing | -- | -11.97% | -76.20% | -156.56% | 97.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 88.34% | -321.35% | -190.97% | 134.28% |